OTCPK:YIHCF (China)
Â
Ordinary Shares - Class H
$
0.55
0 (0%)
12:09 AM EST
Business Description
Yichang HEC ChangJiang Pharmaceutical Co Ltd
ISIN : CNE1000023R6
Share Class Description:
YIHCF: Ordinary Shares - Class HCompare
Compare
Traded in other countries / regions
01558.Hong KongYIHCF.USA IPO Date
2020-09-15Description
Yichang HEC ChangJiang Pharmaceutical Co Ltd functions in the Chinese drug industry. As a domestic manufacturing wing of the HEC Group, Yichang employs its therapeutic technology to address viral, endocrine, metabolic, and cardiovascular diseases. The company's key revenue driver is the anti-viral product division, which manufactures its key product, Its products include Kewei, Ertongshu, Xinhaining, Oumeining and Xining.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.65 | |||||
| Equity-to-Asset | 0.69 | |||||
| Debt-to-Equity | 0.27 | |||||
| Debt-to-EBITDA | 1.27 | |||||
| Interest Coverage | 14.99 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 2.62 | |||||
| Beneish M-Score | -1.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 45.9 | |||||
| 3-Year EBITDA Growth Rate | 32.2 | |||||
| 3-Year EPS without NRI Growth Rate | 119.8 | |||||
| 3-Year Book Growth Rate | 14.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History |
|---|
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.15 | |||||
| Quick Ratio | 1.93 | |||||
| Cash Ratio | 0.6 | |||||
| Days Inventory | 139.82 | |||||
| Days Sales Outstanding | 109.14 | |||||
| Days Payable | 87.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | 23.54 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 78.89 | |||||
| Operating Margin % | 39.28 | |||||
| Net Margin % | 29.76 | |||||
| FCF Margin % | -7.11 | |||||
| ROE % | 21.01 | |||||
| ROA % | 12.76 | |||||
| ROIC % | 18.01 | |||||
| 3-Year ROIIC % | -626.04 | |||||
| ROC (Joel Greenblatt) % | 30.58 | |||||
| ROCE % | 20.88 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 4.51 | |||||
| Forward PE Ratio | 1.95 | |||||
| PE Ratio without NRI | 3.57 | |||||
| Shiller PE Ratio | 11.09 | |||||
| Price-to-Owner-Earnings | 152.67 | |||||
| PS Ratio | 1.34 | |||||
| PB Ratio | 0.86 | |||||
| Price-to-Tangible-Book | 1.22 | |||||
| Price-to-Operating-Cash-Flow | 16.27 | |||||
| EV-to-EBIT | 4.52 | |||||
| EV-to-EBITDA | 4.52 | |||||
| EV-to-Revenue | 1.49 | |||||
| EV-to-FCF | -20.93 | |||||
| Price-to-Projected-FCF | 1.17 | |||||
| Price-to-Graham-Number | 0.44 | |||||
| Price-to-Net-Current-Asset-Value | 4.58 | |||||
| Earnings Yield (Greenblatt) % | 22.12 | |||||
| FCF Yield % | -5.3 | |||||
| Forward Rate of Return (Yacktman) % | 19.29 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:YIHCF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Yichang HEC ChangJiang Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 770.511 | ||
| EPS (TTM) ($) | 0.261 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 0 | ||
| 14-Day ATR ($) | 0 | ||
| 20-Day SMA ($) | 0.55 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range ($) | 0.55 - 0.55 | ||
| Shares Outstanding (Mil) | 879.97 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Yichang HEC ChangJiang Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Yichang HEC ChangJiang Pharmaceutical Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Yichang HEC ChangJiang Pharmaceutical Co Ltd Frequently Asked Questions
What is Yichang HEC ChangJiang Pharmaceutical Co Ltd(YIHCF)'s stock price today?
The current price of YIHCF is $0.55. The 52 week high of YIHCF is $0.55 and 52 week low is $0.55.
When is next earnings date of Yichang HEC ChangJiang Pharmaceutical Co Ltd(YIHCF)?
The next earnings date of Yichang HEC ChangJiang Pharmaceutical Co Ltd(YIHCF) is .
Does Yichang HEC ChangJiang Pharmaceutical Co Ltd(YIHCF) pay dividends? If so, how much?
Yichang HEC ChangJiang Pharmaceutical Co Ltd(YIHCF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers